The Republic of Iceland – Government Debt Management
| Series | RIKB 22 1026 | ||
| Settlement Date | 03/10/2021 | ||
| Total Amount Allocated (MM) | 5,400 | ||
| All Bids Awarded At (Price / Yield) | 109.250 | / | 1.460 |
| Total Number of Bids Received | 2 | ||
| Total Amount of All Bids Received (MM) | 5,400 | ||
| Total Number of Successful Bids | 2 | ||
| Number of Bids Allocated in Full | 2 | ||
| Lowest Price / Highest Yield Allocated | 109.250 | / | 1.460 |
| Highest Price / Lowest Yield Allocated | 109.250 | / | 1.460 |
| Lowest Price / Highest Yield Allocated in Full | 109.250 | / | 1.460 |
| Weighted Average of Successful Bids (Price/Yield) | 109.250 | / | 1.460 |
| Best Bid (Price / Yield) | 109.250 | / | 1.460 |
| Worst Bid (Price / Yield) | 109.250 | / | 1.460 |
| Weighted Average of All Bids Received (Price / Yield) | 109.250 | / | 1.460 |
| Percentage Partial Allocation (Approximate) | 100.00 % | ||
| Bid to Cover Ratio | 1.00 | ||
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Io Therapeutics, Inc.6.12.2025 14:05:00 CET | Press release
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma
Scatec ASA6.12.2025 08:00:00 CET | Press release
Scatec starts commercial operation at Grootfontein solar power plant in South Africa
Junshi Biosciences6.12.2025 04:11:15 CET | Press release
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Zealand Pharma5.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
AlphaTON Capital5.12.2025 18:19:57 CET | Press release
AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom